Capital expenditure increased 101.2%
Capital expenditure changed +101.2% from the comparable as-filed period.
$39.8M→$80.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CIEN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities increased 23.4%
Current liabilities changed +23.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.1B→$1.4B4 prior comparisons
Operating cash flow increased 12.6%
Operating cash flow changed +12.6% from the comparable as-filed period.
$174.3M→$196.3M2 prior comparisons
Operating cash flow / net income decreased 78.7%
Operating cash flow / net income changed -78.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.47→0.742 prior comparisons
Free-cash-flow margin moved 408 bp lower
Free-cash-flow margin changed -408 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
11.04%→6.96%2 prior comparisons
Receivables / revenue moved 1029 bp lower
Receivables / revenue changed -1029 basis points from the comparable as-filed period.
84.10%→73.82%2 prior comparisons
Debt / equity moved 5048 bp higher
Debt / equity changed +5048 basis points from the comparable as-filed period.
55.18%→105.66%2 prior comparisons
Operating cash-flow margin moved 255 bp lower
Operating cash-flow margin changed -255 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.30%→11.74%2 prior comparisons
R&D / revenue moved 321 bp lower
R&D / revenue changed -321 basis points from the comparable as-filed period.
17.38%→14.16%2 prior comparisons
Debt / revenue moved 6714 bp higher
Debt / revenue changed +6714 basis points from the comparable as-filed period.
126.13%→193.27%2 prior comparisons
Stockholders' equity increased 9.7%
Stockholders' equity changed +9.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.8B→$3.1B2 prior comparisons
Stock-based compensation increased 23.3%
Stock-based compensation changed +23.3% from the comparable as-filed period.
$46.9M→$57.9M2 prior comparisons
Research & development increased 11.7%
Research & development changed +11.7% from the comparable as-filed period.
$211.9M→$236.7M2 prior comparisons
Capex / revenue moved 152 bp higher
Capex / revenue changed +152 basis points from the comparable as-filed period.
3.26%→4.78%2 prior comparisons
Current ratio increased 15.7%
Current ratio changed +15.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
3.28→3.84 prior comparisons
Shares outstanding increased 0.5%
Shares outstanding changed +0.5% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
141,055,908→141,808,5258 prior comparisons
SBC / revenue moved 39 bp lower
SBC / revenue changed -39 basis points from the comparable as-filed period.
3.85%→3.46%2 prior comparisons
Inventory increased 1.3%
Inventory changed +1.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$860.4M→$872.0M4 prior comparisons
Net income changed across a low base
Net income changed +2333.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$9.0M→$218.2M3 prior comparisons
Research & development increased 10.7%
Research & development changed +10.7% from the comparable as-filed period.
$214.9M→$237.9M3 prior comparisons
Cash & equivalents increased 10.0%
Cash & equivalents changed +10.0% from the comparable as-filed period.
$949.8M→$1.0B2 prior comparisons
Debt unchangedd 0.0%
Debt changed +0.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$11.6M→$11.6M4 prior comparisons
SBC / revenue moved 73 bp lower
SBC / revenue changed -73 basis points from the comparable as-filed period.
4.26%→3.53%3 prior comparisons
Stock-based compensation increased 15.7%
Stock-based compensation changed +15.7% from the comparable as-filed period.
$48.0M→$55.5M3 prior comparisons
Inventory decreased 7.5%
Inventory changed -7.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$874.3M→$808.4M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.